Cspc Pharmaceutical Group
(OTC) CHJTF
Cspc Pharmaceutical Group Financials at a Glance
Market Cap
$11.75B
Revenue (TTM)
$40.27B
Net Income (TTM)
$6.33B
EPS (TTM)
$0.05
P/E Ratio
21.98
Dividend
$0.03
Beta (Volatility)
0.03 (Low)
Dividend
$0.03
Beta (Volatility)
0.03 (Low)
Price
$1.02
Volume
400
Open
$1.02
Price
$1.02
Volume
400
Open
$1.02
Previous Close
$1.02
Daily Range
$1.02 - $1.02
52-Week Range
$0.54 - $1.39
Dividend
$0.03
Beta (Volatility)
0.03 (Low)
Price
$1.02
Volume
400
Open
$1.02
Previous Close
$1.02
Daily Range
$1.02 - $1.02
52-Week Range
$0.54 - $1.39
CHJTF News
CHJTF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cspc Pharmaceutical Group
Industry
Pharmaceuticals
Sector
Health CareEmployees
21,400
CEO
Cui Long Zhang
Website
www.cspc.com.hkHeadquarters
Shijiazhuang, 050035, CN
CHJTF Financials
Key Financial Metrics (TTM)
Gross Margin
67%
Operating Margin
16%
Net Income Margin
15%
Return on Equity
11%
Return on Capital
12%
Return on Assets
9%
Earnings Yield
4.55%
Dividend Yield
0.03%
Payout Ratio
45.42%
Stock Overview
Market Cap
$11.75B
Shares Outstanding
11.52B
Volume
400
Short Interest
0.00%
Avg. Volume
829.967
Financials (TTM)
Gross Profit
$21.60B
Operating Income
$5.71B
EBITDA
$6.86B
Operating Cash Flow
$4.53B
Capital Expenditure
$2.68B
Free Cash Flow
$1.86B
Cash & ST Invst.
$8.25B
Total Debt
$507.33M
Cspc Pharmaceutical Group Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.82B
-77.4%
Gross Profit
$9.54B
+66.9%
Gross Margin
5.26%
N/A
Market Cap
$11.75B
N/A
Market Cap/Employee
$549.20K
N/A
Employees
21,400
N/A
Net Income
$348.53M
-77.3%
EBITDA
$3.48B
+82.5%
Quarterly Fundamentals
Net Cash
$858.78M
-92.6%
Accounts Receivable
$9.44B
-0.4%
Inventory
$2.87B
+4.3%
Long Term Debt
$158.75M
-23.2%
Short Term Debt
$336.25M
+61.3%
Return on Assets
8.85%
N/A
Return on Invested Capital
12.40%
N/A
Free Cash Flow
$287.78M
-34.3%
Operating Cash Flow
$452.37M
-70.0%